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438 The Journal of Thoracic and CardioObjective: There is a strong association between reflux and end-stage lung disease,
especially idiopathic pulmonary fibrosis. The presence of reflux after lung trans-
plantation might predispose to the development of bronchiolitis obliterans. We
evaluated the risk and physiologic effect of laparoscopic fundoplication in patients
on the lung transplant waiting list.
Methods: One hundred forty-nine patients on the lung transplant waiting list
between March 2001 and January 2005 were evaluated. Nineteen were found to
have a history of reflux, continued symptoms, and severe reflux by means of pH and
manometric studies and underwent laparoscopic fundoplication. The postoperative
course of these 19 patients, including lung function, was retrospectively reviewed.
Postoperatively, the lung function of the 14 patients with idiopathic pulmonary
fibrosis who underwent the laparoscopic Nissen procedure was compared with that
of 31 patients with idiopathic pulmonary fibrosis on the transplant waiting list who
did not undergo fundoplication.
Results: There were no perioperative complications and no decrease in lung function
over the 15-month average follow-up. Exercise capacity remained stable, as deter-
mined on the basis of 6-minute walk distance. Patients with idiopathic pulmonary
fibrosis treated with fundoplication had stable oxygen requirements, whereas control
patients with idiopathic pulmonary fibrosis on the waiting list had a statistically
significant deterioration in oxygen requirement.
Conclusions: Laparoscopic fundoplication can be performed safely in patients with
end-stage lung disease awaiting lung transplantation. Overall, these patients main-
tained stable lung function during the follow-up period. When compared with a
control group of patients with idiopathic pulmonary fibrosis not undergoing fundo-
plication, there was stabilization of oxygen requirement. A larger prospective trial
evaluating the effect of laparoscopic fundoplication on underlying lung function in
this patient population is warranted.
There is an association between gastroesophageal reflux disease (GERD) anda wide range of pulmonary disorders, including pneumonia, asthma, bron-chiectasis, and cystic fibrosis. More recently, an association between GERD
and interstitial lung disease, especially idiopathic pulmonary fibrosis (IPF), has been
proposed.1 Several decades ago, the incidence of GERD and hiatal hernia was
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TXreported to be higher in a group of patients with interstitial
pulmonary fibrosis than in age-matched control subjects.2
More recently, 17 consecutive patients with biopsy-proved
interstitial pulmonary fibrosis were studied with ambulatory
esophageal pH probes. Sixteen (94%) of the 17 patients
were found to have abnormal esophageal acid exposure at
significantly higher levels than that seen in control patients
with other types of interstitial lung disease.3 It has been
hypothesized that recurrent overt or silent regurgitation and
aspiration might play a role in the progression of these and
other pulmonary disorders.
It has also been proposed that GERD is a potential cause
of allograft dysfunction after lung transplantation, and as a
result, laparoscopic Nissen fundoplication might be a suit-
able method to prevent the development of bronchiolitis
obliterans after transplantation. Davis and colleagues4
showed a 76% incidence of GERD documented by means of
pH-probe analysis in a series of patients who underwent
lung transplantation. Surgical fundoplication after lung
transplantation in these patients resulted in improved forced
expiratory volume in 1 second (FEV1) and a decrease in the
incidence of bronchiolitis obliterans compared with that
seen in historical control subjects. Moreover, fundoplication
early (approximately 1 month) after transplantation resulted
in a higher freedom from development of bronchiolitis
obliterans and better survival when compared with late
fundoplication (2 years) after transplantation.5 This report
represents the largest series of surgical fundoplication after
lung transplantation.
We reasoned that fundoplication might best be per-
formed in selected patients before lung transplantation to
potentially reduce morbidity and in some cases to stabilize
the patient’s end-stage pulmonary status. We show here that
laparoscopic fundoplication in patients with end-stage lung
disease can be safely accomplished before lung
transplantation.
There might be several advantages to performing the
antireflux procedure before transplantation. First, it allows
for the earliest degree of protection from the negative ef-
fects of reflux on the transplanted lung. Second, it might
offer protection from aspiration around the time of trans-
Abbreviations and Acronyms
COPD chronic obstructive pulmonary disease
DLCO  diffusing capacity of lung for carbon
monoxide
FEV1  forced expiratory volume in 1 second
GER  gastroesophageal reflux
GERD gastroesophageal reflux disease
IPF  idiopathic pulmonary fibrosisplantation. Third, there is the potential for improvement of
The Journal of Thoracinative lung function and alteration of progression of under-
lying disease.
Patients and Methods
One hundred forty-nine patients listed on the lung transplant
waiting list between March 2001 and January 2005 at Brigham and
Women’s Hospital were evaluated for a history of GERD and
symptoms of heartburn or regurgitation. Nineteen were found to
have a history of GERD, continued classical symptoms of GERD,
and severe reflux documented by means of pH studies and under-
went laparoscopic fundoplication. A retrospective analysis of these
patients was performed with the approval of the institutional
review board (approval date: June 30, 2004). All patients were
referred for pulmonary rehabilitation at the time of consideration
for lung transplantation.
Esophageal Assessment
Before selection as lung transplant candidates, patients were inter-
viewed for a history of GERD and symptoms of heartburn or
regurgitation. If any of these were present, they were referred for
esophageal testing, which consisted of esophageal manometry,
24-hour ambulatory pH testing, and endoscopy. Evidence of
pathologic reflux was considered to be increased esophageal acid
exposure relative to normal values and was specifically defined as
total acid exposure of greater than 4.0% or a composite Demeester
reflux score of greater than 14.72 (95th percentile). Secondary data
in support of the diagnosis of GERD included abnormalities on
endoscopy, such as the presence of erosions, ulceration, or stricture
or hiatal herniation on endoscopy, or abnormalities on esophageal
manometry, such as reduction of resting lower esophageal sphinc-
ter pressure. Those with evidence of pathologic esophageal acid
exposure and continued symptoms with medical therapy were
referred for laparoscopic fundoplication.
Preoperative and Perioperative Pulmonary Assessment
Preoperative characteristics, including age, sex, underlying pulmo-
nary disease, immunosuppressive medications, oxygen depen-
dence, pulmonary function testing, and 6-minute walk distance,
were collected (Table 1). The perioperative course of each patient,
including length of stay and any complications, was reviewed. The
postoperative course of these 19 patients, including oxygen depen-
dence, 6-minute walk distance, and pulmonary function testing,
and any symptoms of heartburn or regurgitation were retrospec-
tively reviewed, with a mean overall follow-up of 15 months. Not
all patients had preoperative or postoperative 6-minute walk dis-
tances, preoperative or postoperative diffusion capacity, or post-
operative pulmonary function test results available.
Fourteen of the patients undergoing laparoscopic Nissen fun-
doplication had IPF. Their postoperative course, including FEV1,
forced vital capacity, diffusing capacity of lung for carbon mon-
oxide (DLCO), 6-minute walk distances, and oxygen requirement,
were retrospectively compared with those of patients with IPF on
the waiting list who did not undergo fundoplication.
Technique of Laparoscopic Nissen Fundoplication
Laparoscopic fundoplication was performed through 5 ports. Com-
plete division of the majority of the short gastric vessels was
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interrupted Ethibond sutures (Ethicon, Inc, Somerville, NJ). If
there was any tension on the necessary 4 cm of intra-abdominal
esophagus, then the esophagus was deemed short, and a Collis-
Nissen procedure was performed. With a 56F to 60F (depending
on the patient’s body mass) bougie in place along the lesser curve
of the stomach, an endoscopic GIA stapler was used to remove a
triangular portion of fundus, essentially lengthening the intra-
abdominal portion. A 2½-cm calibrated Nissen fundoplication was
typically performed with 3 stitches, the first 2 incorporating esopha-
gus. Patients were not allowed anything by mouth overnight and were
started on clear liquids the next day. After tolerating full liquids on
postoperative day 2, they were sent home on a full liquid diet for 2
weeks.
Statistical Analysis
The  notation is used to report the sample standard deviation.
The Spearman rank-order correlation coefficient was used as the
measure of association between Demeester score and mean lower
esophageal sphincter pressure with preoperative lung function and
walk distance. The P value was computed by means of the Monte
Carlo method for a 1-sided test that reflects the prior hypothesis of
a positive correlation between the severity of gastroesophageal
reflux (GER) and the severity of underlying lung disease. The
comparison of preoperative and postoperative lung function or
walk distance was based on the Wilcoxon signed-rank test. The
exact P value is reported as 1 sided to rule out significantly
decreasing lung function. The nonparametric tests were performed
with StatXact 6 (Cytel Software Corp, Cambridge, Mass).
The patients with IPF who underwent laparoscopic fundopli-
cation were compared with a control group with the same diagno-
sis on the transplant waiting list during the same period in terms of
their changes in lung function, exercise capacity, and oxygen
requirement over time. Each change was standardized by the time
interval between the initial and follow-up tests to account for the
TABLE 1. Preoperative patient characteristics (n  19)
Average age 53 10 y
Underlying lung disease, n
Interstitial pulmonary fibrosis 14
Cystic fibrosis 1
COPD 3
Immotile cilia 1
Severity of GERD
Average Demeester index 97.5 (14.72, 95th percentile)
Average resting LES 3.7 1.7 mm Hg
Lung function
Average FEV1 55% 24%
Average FVC 62% 18%
Average adjusted DLCO 35% 15%
Immunosuppression 12 (63%)
Oxygen dependence 12 (63%)
COPD, Chronic obstructive pulmonary disease; GERD, gastroesophageal
reflux disease; LES, lower esophageal sphincter; FEV1, forced expiratory
volume in 1 second; FVC, forced vital capacity; DLCO, diffusing capacity of
lung for carbon monoxide.varying intervals of follow-up testing among the patients, and
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each test were analyzed by using the Wilcoxon rank sum test to
determine whether a difference was present between the fundopli-
cation and control groups. The 2-sided P values were computed by
using the exact algorithm in SAS 8.2 (SAS Institute Inc, Cary, NC).
Results
Patient Population and Perioperative Events
Of 149 patients on the lung transplant waiting list between
March 2001 and January 2005 at Brigham and Women’s
Hospital, 19 (12.8%) were found to have a history of sig-
nificant GERD, continued symptoms on full medical ther-
apy, diminished lower esophageal sphincter tone, and se-
vere esophageal acid exposure, as determined by means of
ambulatory pH study. These patients underwent laparo-
scopic Nissen fundoplication. Fourteen had IPF, 3 had
chronic obstructive pulmonary disease (COPD), 1 had im-
motile cilia syndrome, and 1 had cystic fibrosis. The aver-
age patient age was 53  10 years. Twelve of the 19
patients were on immunosuppressive regimens (6 were re-
ceiving corticosteroids) before the laparoscopic Nissen pro-
cedure. The incidence of complications was not higher for
this group of patients.
Mean patient follow-up was 15  8 months among the
13 patients who had undergone any of the lung function
tests or 6-minute walk postoperatively. For the evaluation of
the effect of laparoscopic Nissen fundoplication on native
lung function, the follow-up interval of patients undergoing
transplantation was terminated at the time of transplanta-
tion. The 4 patients undergoing transplantation were further
observed during the perioperative transplantation period for
episodes of aspiration. The patient who underwent a lapa-
roscopic Toupet fundoplication experienced an episode of
aspiration 5 days after transplantation but recovered and
was discharged home on postoperative day 20. No other
patient undergoing transplantation had aspiration or symp-
toms of recurrent reflux. Of the 4 patients undergoing trans-
plantation, 1 had new symptoms of nausea and early satiety
after transplantation. The patient was found to have signif-
icantly delayed gastric emptying, which improved with
metoclopramide.
Four of the patients who underwent laparoscopic Nissen
fundoplication died before being offered lung transplanta-
tion at 2, 6, 12, and 19 months after the antireflux procedure.
All deaths were a result of progressive respiratory failure
and were unrelated to the surgical procedure. Three of these
4 patients had the lowest DLCO value among the 19 patients
(adjusted DLCO  9% [died 2 months after Nissen fundo-
plication], 12% [died 6 months after Nissen fundoplication],
19% [died 19 months after Nissen fundoplication], and 46%
[died 12 months after Nissen fundoplication]).
Of 45 patients with IPF on the transplant waiting list, 14
(31%) had symptoms and severe GERD confirmed by
means of pH study and underwent laparoscopic Nissen
uary 2006
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list did not undergo laparoscopic Nissen fundoplication.
pH, Manometric Studies, and Endoscopic Findings
The average Demeester score before fundoplication was
97.5 81.1 (normal is considered14.72, 95th percentile).
The mean resting lower esophageal sphincter pressure
(above gastric pressure) was 3.7  1.7 mm Hg. One patient
was found to have significantly diminished esophageal body
contractility with swallows, manifesting as reduced contrac-
tion incidence and amplitude. He underwent a Toupet (par-
tial) fundoplication. The remainder showed no significant
impairment of motility. The severity of preoperative GER,
as determined on the basis of the Demeester score, corre-
lated positively with preoperative oxygen requirement (cor-
relation coefficient, 0.49; P  .028; Figure 1).
All patients undergoing Nissen fundoplication under-
went preoperative endoscopy. No patients were found to
have stricture or Barrett’s esophagus. Three were seen to
have evidence of esophagitis. It should be noted that the
majority of these patients had been receiving long-term
proton-pump inhibitors until 1 week before their pH study
and endoscopy.
Figure 1. Correlation of preoperative oxygen dependence with
Demeester Score.
TABLE 2. Average lung function and exercise capacity in
plication indices measured: All diagnoses
Parameter
N
(number with both pre and post
measurements)
Oxygen requirement (L/min) 15
6-Min walk (ft) 10
FVC (% predicted) 11
FEV1 (% predicted) 11
DLCO (% predicted, adjusted) 8
P  .05 indicates no statistically significant change. Pre, Prefundoplicatio
volume in 1 second; DLCO, diffusing capacity of lung for carbon monoxide.
The Journal of ThoraciPatients did not undergo routine postoperative pH/man-
ometric testing. Because all those who underwent fundopli-
cation had current symptomatic reflux, they were followed
postoperatively for symptoms. Only one patient underwent
postoperative pH/manometric testing because of symptoms
of nausea. Her postoperative Demeester score was 20 (pre-
operative value, 86.8), and her nausea resolved spontane-
ously. Although none of the patients complained of recur-
rent heartburn or regurgitation, 13 of the 19 patients were
restarted on acid-suppressive therapy to reduce the risk of
gastritis or peptic ulcer associated with corticosteroid
therapy.
Surgical Results
Fifteen patients underwent laparoscopic Nissen fundoplica-
tion, 3 underwent laparoscopic Collis-Nissen fundoplica-
tion, and 1 underwent laparoscopic Toupet fundoplication.
Average length of stay was 3.5  1.2 days (range, 2-6
days). One of the patients undergoing laparoscopic Nissen
fundoplication required conversion to open Nissen fundo-
plication because of body habitus and gastric perforation.
This patient required 2 dilations as an outpatient for recur-
rent stricture and is now swallowing without difficulty. This
patient and 2 others experienced superficial wound infec-
tions requiring antibiotics. One patient had transient post-
operative gastric dilation. A single patient had symptoms of
nausea 6 months after the Nissen procedure and was eval-
uated with postoperative pH studies (see above). None of
the patients had recurrent symptoms of either heartburn or
regurgitation.
Lung Function
Table 2 shows the comparison among patients who had each
type of assessment evaluated both preoperatively and post-
operatively. Thus the preoperative summaries in Tables 1
and 2 reflect some fluctuations but are not significantly
different. The overall follow-up interval was 15 months, as
measured from the date of Nissen fundoplication. Overall,
e patients who had both prefundoplication and postfundo-
Pre,
edian  SD
Post,
median  SD
Median interval,
mo P value
2.4 2.2 2.4 2.2 12.7 .500
1283 344 1231 199 7.1 .500
65 15 61 16 9.5 .093
54 19 54 24 9.5 .167
43 14 40 18 6.8 .242
st, postfundoplication; FVC, forced vital capacity; FEV , forced expiratorythos
m
n; Po 1
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DLCO, and 6-minute walk distances showed no statistically
significant decreases over the follow-up intervals. Twelve
patients were oxygen dependent before the procedure, and
there was no significant change in the degree of oxygen
dependence after the procedure.
One patient with IPF had significant improvements in his
FEV1 (77% to 103%), decrease in supplemental oxygen
requirement, and subjective reduction of shortness of
breath. He elected to be taken off the transplant waiting list.
Comparison of Patients With IPF Undergoing Nissen
Fundoplication With Control Patients With IPF
In an attempt to determine whether the stability of lung
function and exercise capacity noted overall in the patients
undergoing Nissen fundoplication represented a difference
from that expected in patients with IPF overall, we retro-
spectively compared patients with IPF undergoing laparo-
scopic Nissen fundoplication (14 patients) with those not
undergoing fundoplication (31 patients). The results, includ-
ing initial and follow-up values, intervals, and 2-sided P
values are listed in Table 3. The results indicate that there is
a statistically significant difference in the oxygen require-
ments over time between the patients with IPF undergoing
Nissen fundoplication and those not undergoing Nissen
fundoplication.
Discussion
The incidence of severe GERD in patients with end-stage
lung disease awaiting lung transplantation is high. One
study of a subset of patients undergoing transplantation
estimated the incidence of pretransplantation GERD at 35%
and the incidence of posttransplantation reflux at 65%.6 All
patients with reflux before transplantation continued to have
reflux after transplantation. In addition, a high incidence of
TABLE 3. Comparison of sequential oxygen requirement,
undergoing Nissen fundoplication with values in those no
Parameter N
Oxygen requirement (L/min) Control group: n 23
Nissen group: n 11
6-Min walk (ft) Control group: n 12 132
Nissen group: n 8 1
FVC (% predicted) Control group: n 14 5
Nissen group: n 8 5
FEV1 (% predicted) Control group: n 14 5
Nissen group: n 8
DLCO (% predicted, adjusted) Control group: n 8 3
Nissen group: n 6
P  .05 indicates a statistically significant difference between the change
Post, postfundoplication; FVC, forced vital capacity; FEV1, forced expiratoGERD has been reported in a variety of patients with
442 The Journal of Thoracic and Cardiovascular Surgery ● Febrend-stage lung disease, including patients with COPD,
asthma, and interstitial lung disease.7,8 In a study of 17
consecutive patients with IPF, 16 (94%) were found to have
abnormal esophageal acid exposure. Only one quarter had
symptoms of heartburn or regurgitation.3
Although numerous publications have documented an
association between lung disease and GERD, the underlying
mechanism is still not well understood.9 Patients with
COPD and asthma have similar physiologic factors that
might exacerbate reflux. During exacerbations, more nega-
tive intrathoracic pressure and correspondingly higher ab-
dominal pressures are produced, favoring increased reflux.
Furthermore, with lung hyperexpansion, the diaphragm is
flattened, potentially interfering with the ability of the crura
to support the lower esophageal sphincter. Theophylline can
increase gastric acid production and decrease lower esoph-
ageal sphincter pressure. -Agonist medications might in-
duce lower esophageal sphincter relaxation.10 Conversely,
GERD might induce bronchoconstriction. Asthmatic sub-
jects could have increased vagal responses to acid in the
esophagus, resulting in bronchoconstriction.11 Microaspira-
tion might result in airway inflammation and bronchospasm.
Several animal studies have shown greater effects on airway
resistance to acid infused directly into the trachea as op-
posed to acid infused into the esophagus; however, a study
on acid infusion in adults with COPD failed to detect any
changes in airway resistance.12
Although there is a clear association between IPF and
GERD, a causal relationship is not clear.13 IPF is charac-
terized by inflammation and fibrosis of the alveolar septae
and terminal bronchioles and is believed to be immune
mediated, with activation of proinflammatory cytokines re-
sulting in fibroblast proliferation and scarring. A variety of
factors, such as smoking, occupational exposures, viruses,
k distance, and pulmonary function of patients with IPF
ergoing Nissen fundoplication (control group)
edian
nge)
Post, median
(range)
Median (range)
interval, mo P value
0-10) 3.0 (0-15) 13 (1-57)
0-8) 2.5 (0-8) 11 (1-23) .002
618-1955) 989 (180-1908) 14 (4-24)
691-2005) 1241.5 (790-1479) 8 (1-15) .664
42-79) 63 (33-76) 12 (4-65)
45-81) 54 (40-84) 6 (4-16) .881
42-84) 62 (32-81) 12 (4-65)
49-80) 56 (44-103) 6 (4-16) .973
25-50) 26.5 (11-56) 12 (4-65)
27-45) 35 (11-50) 4.5 (4-9) .755
rameters between the Nissen and control groups. Pre, prefundoplication;
ume in 1 second; DLCO, diffusing capacity of lung for carbon monoxide.wal
t und
Pre, m
(ra
2.0 (
3.0 (
4.5 (
283 (
6.5 (
7.5 (
9.5 (
62 (
0.5 (
36 (
in paand GERD, have been associated with IPF. The lack of
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that direct contact with refluxed material does not result in
alveolar injury and inflammation. Rather, the refluxate
might induce an immune response mediated by inflamma-
tory cytokines targeting the alveoli.
Several studies have shown that antireflux medication or
surgical intervention can alleviate respiratory disorders in
certain patients. In patients with GERD (documented by
means of pH probe) and respiratory symptoms consisting of
chronic cough or asthma, 71% have good control of their
respiratory symptoms after medical antireflux therapy.14 In
a randomized controlled study of selected asthmatic pa-
tients, patients treated with medication or antireflux surgery
required less asthma medication and had improved symp-
toms compared with those receiving placebo. Furthermore,
there was evidence that those patients treated with surgical
intervention had the greatest benefit. Fifty percent of pa-
tients treated with antireflux surgery in this study versus
only 5% of patients treated with placebo had no respiratory
symptoms at 6 years.15 In another study improvement in
asthma was seen in 75% of patients who underwent Nissen
fundoplication but in only 9% of patients who were treated
medically. The asthma score improved 43% in the surgical
group versus only 10% in the medical group.16
The greatest impediment to long-term survival after lung
transplantation is chronic rejection consisting of inflamma-
tion and fibrosis of the small airways, a process termed
obliterative bronchiolitis. This chronic bronchial injury is
believed to be immune mediated. It is unclear what role
chronic reflux of gastric contents, acid, or both into the
bronchial tree might play in this process. A recent study of
laparoscopic fundoplication after lung transplantation dem-
onstrated a decrease in the incidence of bronchiolitis oblit-
erans syndrome in patients who underwent the procedure
after transplantation. Patients undergoing lung transplanta-
tion who had reflux determined by means of pH study and
who underwent laparoscopic Nissen fundoplication demon-
strated a 24% improvement in percent predicted FEV1.4
Because the diagnosis of bronchiolitis obliterans syndrome
is largely determined by a decrease in FEV1 not attributable
to other causes, the incidence of this clinical syndrome was
lower in these patients, although it is not clear if the under-
lying process of chronic rejection was altered.
A follow-up retrospective study at the same institution
noted that the incidence of posttransplantation reflux, as
determined by means of pH probe, was 76%. They further
divided the posttransplantation laparoscopic Nissen group
into those antireflux procedures done early (ie, within 90
days) after transplantation and those done late after trans-
plantation. In the 14 patients who underwent early fundo-
plication, 3-year survival was 100%, whereas 3-year sur-
vival was 86% in patients with reflux and late surgical
intervention and 69% in patients with reflux and no surgical
The Journal of Thoraciintervention. Freedom from bronchiolitis obliterans syn-
drome at 3 years was 100% in the group undergoing early
surgical intervention compared with 60% in patients with
reflux and no surgical intervention and 47% in patients with
reflux and late surgical intervention.5 Thus there is reason-
able evidence to support the notion that prophylactic surgi-
cal fundoplication soon after transplantation or even before
transplantation might prevent the decrease in lung function
often seen after transplantation.
An antireflux procedure before transplantation might of-
fer several advantages. First, this procedure offers immedi-
ate protection from the effects of reflux on the potential
decrease in lung function after transplantation. Second,
there is the potential benefit of reducing the risk of periop-
erative aspiration and pneumonia. In instances of perioper-
ative aspiration and respiratory failure, some surgeons have
even advocated performing a Nissen procedure before ex-
tubation. Our approach might avoid this difficult situation.
Third, a large percentage of patients with IPF have reflux,
and progression of their disease might, in part, be due to the
effects of acid aspiration on the native lungs. Fundoplica-
tion in these patients or even in patients with early usual
interstitial pneumonia might halt disease progression.
Although it has been argued that patients with GER and
end-stage lung disease are at high risk for reflux surgery, our
series demonstrates that laparoscopic Nissen fundoplication
can safely be performed in this group of patients before
transplantation. There were no serious complications after
laparoscopic fundoplication in these 19 patients, despite
their poor lung function (average preoperative FEV1 of 55%
of predicted value and average DLCO of 35% of predicted
value). The average length of stay was 3.5 days, and no
patient was in the hospital longer than 6 days. Four patients
died before transplantation. There was no association be-
tween surgical intervention and their deaths. These patients
had some of the lowest DLCO values in the group and clearly
had advanced IPF. The variability in getting an appropri-
ately matched lung allograft in time for a given patient with
IPF is such that we are not able to recommend a cutoff as to
who should not be offered fundoplication before surgical
intervention.
There are isolated reports of improvement after antire-
flux procedures in patients with interstitial lung disease.
Overall, the patients undergoing fundoplication in our series
showed no significant decrease in lung function or increase
in oxygen requirements. When the patients with IPF under-
going fundoplication (14 of the total 19 patients undergoing
fundoplication) were retrospectively compared with patients
with IPF on the transplant waiting list who had not under-
gone fundoplication, a highly statistically significant differ-
ence was seen in oxygen requirements over time. Patients
with IPF undergoing Nissen fundoplication showed a de-
crease in the average oxygen requirement from 3.0 to 2.5
c and Cardiovascular Surgery ● Volume 131, Number 2 443
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increase in the average oxygen requirement from 2.0 to 3.0
L/min (P  .002). No significant differences were noted in
lung function tests or 6-minute walk distances, possibly
because the follow-up interval for these tests to date is
shorter, and it might take time for differences to become
apparent. Further follow-up might or might not reveal dif-
ferences in these parameters over time.
A limitation of this retrospective study is that not all
patients had complete preoperative and postoperative pul-
monary function test, 6-minute walk, and oxygen data re-
corded. It should be emphasized that this study is not
randomized, and the experimental and control groups are
not equal. The patients undergoing Nissen fundoplication
were, for the most part symptomatic, whereas the control
patients were largely asymptomatic. The patients undergo-
ing Nissen fundoplication in all likelihood had a higher
incidence of reflux and more severe reflux, but this cannot
be known without 24-hour pH-probe testing in all patients.
Likewise, we are considering obtaining post-Nissen pH/
manometric studies in all patients. Although no patients
complained of postoperative heartburn or regurgitation,
most were on acid-suppressive therapy because of associ-
ated corticosteroid use. This therapy can mask symptoms of
an inadequate repair and allows for nonacid reflux. Any
potential benefits of fundoplication on lung function will
only be seen if the repair effectively reduces reflux.
We believe that because of prior reports of a high inci-
dence of asymptomatic reflux in patients with IPF3 and
because of the positive findings of this study, every patient
with IPF on the waiting list should be considered for 24-
hour pH-probe screening. There is reason to believe that if
correction of reflux improves or stabilizes lung function in
those with end-stage lung disease, correction earlier in the
course of the disease (ie, at time of diagnosis of IPF) might
be more effective in preventing deterioration of lung func-
tion. A prospective, randomized, 3-armed trial comparing
maximal medical therapy, placebo, and surgical therapy
would be necessary to evaluate the effect of intervention on
underlying lung disease.
Conclusion
There is a high incidence of symptomatic and severe GERD
in patients with IPF. The severity of GER correlates with the
degree of preoperative oxygen dependence. Laparoscopic
surgical fundoplication can be performed safely in these pa-
tients and patients with other end-stage lung diseases awaiting
lung transplantation. No patient had recurrent symptoms of
discomfort or reflux, and no patient who underwent complete
fundoplication experienced aspiration around the time of lung
transplantation. With a mean follow-up of 15 months, exer-
cise capacity and lung function in those who underwent
postoperative testing showed no significant decrease. When
444 The Journal of Thoracic and Cardiovascular Surgery ● Febrcompared with a control group of patients with IPF on the
waiting list who did not undergo transplantation, there was
an improvement in the oxygen requirement of the patients
treated with fundoplication. The role of GER in the pro-
gression of underlying lung disease is not clear, and a
randomized study is needed to define any benefit of surgical
fundoplication in these patients.
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Discussion
Dr Pasquale Ferraro (Montreal, Quebec, Canada). Congratula-
tions, Dr Linden, on a fine presentation. Your group certainly has
to be commended on doing these types of operations in high-risk
patients.
I have a number of comments before moving on to the ques-
tions. First of all, I reviewed this article not only from the per-
uary 2006
Linden et al Cardiothoracic Transplantation
TXspective of an esophageal surgeon but also that of a lung trans-
plantation surgeon. A number of recent studies have provided
thought-provoking data on nonalloimmune injury with the possible
association between reflux disease and bronchiolitis obliterans. We
all know that 50% of our patients undergoing lung transplantation
have bronchiolitis obliterans on long-term follow-up, despite im-
proved immunosuppression, decreased incidence of acute rejec-
tion, and better lung preservation. The pioneering work of Davis
and colleagues from Duke has provided fascinating insight. To
date, however, much of the data have been incomplete or incon-
clusive for a number of reasons. Studies are retrospective in nature;
sample sizes are small; data comparing preoperative and postop-
erative esophageal assessment, including endoscopic results, have
not been provided; comparison with effective medical therapy has
not been carried out; and long-term follow-up is not available.
Nonetheless, the development of bronchiolitis obliterans and its
devastating effect on the patient’s quality of life and long-term
survival certainly warrants a serious look at measures for control-
ling reflux disease after transplantation. Whether it should be done
in patients on a waiting list before transplantation is a more
important question rather than trying to establish its feasibility
from a technical standpoint.
My first question is this. When looking at the data, the patients
in your series do not appear to be severely compromised, with
close to 40% not requiring oxygen and having a mean FEV1 of
54%. How are patients selected with respect to the severity of their
lung disease? Would high oxygen requirements or moderate pul-
monary hypertension be a contraindication? Does this not repre-
sent an important selection bias?
Dr Linden. Thank you for your comments. We selected pa-
tients for operation as they were initially placed on the waiting list.
They were evaluated for symptoms, and if they had persistent
symptoms despite proton pump inhibitor therapy and were found
to have a positive pH test result, they underwent laparoscopic
fundoplication surgery. Therefore in a sense these represent pa-
tients at the end stage of lung disease but at the earliest stage on the
waiting list. Some patients had significant oxygen requirements
(ie, 4, 5, 6, and even 8 L/min for some), and they all met the
criteria to be on the waiting list. Therefore they all did have
significant impairments of lung function, even though they might
have been just placed on the waiting list.
Dr Ferraro. How can you discuss surgical results of fundopli-
cation without providing and comparing preoperative and postop-
erative data on pH studies, manometry, and endoscopic findings?
Are symptoms alone a reliable indicator of reflux disease in this
type of patient?
Dr Linden. You are correct in that the majority of patients with
end-stage lung disease might actually have reflux without symp-
toms. We initially started out being as conservative as possible in
picking out only those patients with the most severe reflux to fix.
All of these patients were symptomatic before the operation, and
after the operation, they did not have any classical symptoms of
heartburn or regurgitation. Therefore I agree with you that it would
be best to have prefundoplication and postfundoplication 24-hour
pH-probe data, but because they were symptomatic preoperatively,
we chose to follow symptoms postoperatively.
Dr Ferraro. In your conclusion you state, and I quote, “Lung
function and exercise capacity showed no significant decrease after
The Journal of Thoracifundoplication.” Is it possible that the natural course of the disease,
especially in COPD, or that a change in medical management, such
as the use of prednisone or immunosuppressive agents, is respon-
sible for this?
Second, 20% of the patients operated on still died before
transplantation, which is not unlike the rate that is generally
reported for patients on waiting lists in North America. How did
the 130 patients who did not undergo fundoplication evolve?
Dr Linden. The vast majority of our patients had IPF. Immu-
nosupressive therapy, at least with steroid therapy, has been shown
to have no effect on progression of underlying disease. This was
really a feasibility study to show that it can be done safely in these
patients. To really say that this operation improves the underlying
lung function of the patient, one needs a randomized controlled
study. Therefore I would agree with you in that regard.
Dr Steven R. DeMeester (Los Angeles, Calif). I congratulate
you on a very interesting and nice presentation.
This certainly is a fascinating area. One thing that always is
questionable, though, is whether we are looking at the chicken or
the egg. We know that severe pulmonary disease can induce reflux;
likewise, reflux can induce pulmonary disease. Do you have any
insight into some of these patients? Is this chicken or egg in these
patients? In other words, did you look and see how many had
symptoms predating the onset of their significant pulmonary dys-
function in terms of reflux symptoms?
Dr Linden. That is a very good question. No, we did not try to
elicit which symptoms came first. It is interesting to note that in the
patients with IPF, it did not seem to be a motility problem in the
esophagus. They all seemed to have normal manometric results,
unlike some patients with scleroderma, in whom the esophagus
and the lung might both be affected, and all of them had very low
esophageal sphincter tone, maybe elucidating something about the
mechanism, but we do not have any insights as to which causes
what in patients with IPF.
Dr DeMeester. In terms of the mechanism, it is pretty well
demonstrated, and we have some articles out, that the pressure
gradient increases significantly when you have pulmonary disease
in terms of the pressure gradient between thoracic and abdominal
components, and therefore the difficult respiration leads to a large
pressure gradient, which can induce reflux. Along those lines, one
way also to get a sense of the severity or the longevity of the reflux
disease is to look at complications of reflux disease in these
patients. Did any of them have severe esophagitis, strictures, or
Barrett’s esophagus, which would suggest long-standing reflux
disease?
Dr Linden. All patients underwent esophagogastroduodenos-
copy, and Barrett’s esophagus was not seen in any of the patients,
I do not believe, nor was significant stricture. Probably a minority
of them did have some evidence of esophagitis, but as far as severe
sequelae of esophagitis, I do not think we found many with severe
sequelae of esophagitis.
Dr R. Duane Davis, Jr (Durham, NC). I rise to congratulate
you on an excellent presentation.
Again, I think the concern I have is just the appropriate control
in terms of the fact that we know that the natural history in most
of the patients who are referred with pulmonary fibrosis is fairly
dismal, particularly once they get to an FEV1 of about 50%.
Anecdotally, I will say that when we have intervened earlier than
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the expected course. Therefore I would say that you really do need
to kind of look at what your natural history is of the patients and
try to do a case-control study.
The patient that you wrapped with a Toupet, I understand the
rationale for doing it. Was the aspiration event actually something
that you thought was coming from the stomach, or do you think
this was something that was more of a primary esophageal prob-
lem?
Dr Linden. That is a very good question because aspiration can
be a multifactorial event, and in fact, this patient underwent a
video swallow after the event and was noted to have swallowing
dysfunction. Therefore it is not clear in this patient whether his
aspiration event was from swallowing dysfunction or from persis-
tent reflux by an incomplete wrap. Both could have contributed.
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presentation.
You have 19 patients on whom you operated. How many of that
series were receiving medical treatment? What was your policy?
Did you operate on the basis of high-volume reflux with possible
aspiration, or was it more on the symptomatic failure of the
medical treatment? What is your policy in deciding between the
indication for surgical intervention versus medical treatment?
Dr Linden. Well, to date, we have only operated on patients
who were symptomatic and who were symptomatic despite proton
pump inhibitor therapy and were shown to have a positive 24-hour
pH study result. Therefore in a sense, all of these patients met the
classical criteria for fundoplication. Now whether those criteria
should be expanded in the future is something to think about and
discuss.
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